Total Glucosides of Paeony in the development and Prognosis of undifferentiated arthritis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002657

Enrollment

Unknown

Registered

2012-11-03

Start date

2012-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

undifferentiated arthritis

Interventions

TGP group:with TGP treatment

non TGP group:without TGP treatment

Eligibility

Sex/Gender

Male

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. one or more swollen joint sore persisted 6 weeks and longer, and absence of a definite diagnosis of arthritis or diffused connective tissue disease; 2. age >=18 years; 3. disease duration <=6 months; 4. patients who had not received DMARDs or biologic agents; 5. patients who had not received Glucocorticoids.

Exclusion criteria

Exclusion criteria: 1. severe heart, liver or renal disfunction (1.5 times above upper normal limit); 2. alcohol addiction; 3. patients who were pregnant or lactant; 4. chronic diarrhea; 5. the history of allergy for Total Glucosides of Paeony; 6. patients who can not follow the visit.

Design outcomes

Primary

Measure	Time frame
diagnosis;	—

Secondary

Measure	Time frame
Prevalence of side effect;	—

Countries

China

Contacts

Public ContactSu Yin

suyin07@yahoo.com.cn+86 13321120132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026